The neonatal Fc receptor in cancer FcRn in cancer

22Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Since the neonatal IgG Fc receptor (FcRn) was discovered, it was found to be involved in immunoglobulin recycling and biodistribution, immune complexes routing, antigen presentation, humoral immune response, and cancer immunosurveillance. The latest data show that FcRn plays a part in cancer pathophysiology. In various types of cancers, such as lung and colorectal cancer, FcRn has been described as an early marker for prognosis. Dysregulation of FcRn expression by cancer cells allows them to increase their metabolism, and this process could be exploited for passive targeting of cytotoxic drugs. However, the roles of this receptor depend on whether the studied cell population is the tumor tissue or the infiltrating cells, bringing forward the need for further studies.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Cadena Castaneda, D., Brachet, G., Goupille, C., Ouldamer, L., & Gouilleux-Gruart, V. (2020, July 1). The neonatal Fc receptor in cancer FcRn in cancer. Cancer Medicine. Blackwell Publishing Ltd. https://doi.org/10.1002/cam4.3067

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 12

60%

Researcher 5

25%

Professor / Associate Prof. 3

15%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 6

32%

Medicine and Dentistry 5

26%

Pharmacology, Toxicology and Pharmaceut... 4

21%

Immunology and Microbiology 4

21%

Save time finding and organizing research with Mendeley

Sign up for free